L. Blair Shamel
Direttore/Membro del Consiglio presso Nanospectra Biosciences, Inc.
Profilo
L.
Blair Shamel is currently a Director at Nanospectra Biosciences, Inc., a Director at California Prostate Cancer Coalition, and a Member at American Urological Association Education & Research, Inc. Previously, he was the Chief Executive Officer at Navigant Cymetrix Corp.
and the Senior Vice President-Corporate Development at 9342-8530 Québec, Inc. He also has an education background with a graduate degree from Emory University and an undergraduate degree from Rhodes College.
Posizioni attive di L. Blair Shamel
Società | Posizione | Inizio |
---|---|---|
American Urological Association Education & Research, Inc.
American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services American Urological Association Education & Research, Inc. operates a urologic association. It offers urological clinical care through education, research and the formulation of health care policy. The company was founded on February 22, 1902 and is headquartered in Linthicum, MD. | Corporate Officer/Principal | - |
California Prostate Cancer Coalition | Direttore/Membro del Consiglio | - |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di L. Blair Shamel
Società | Posizione | Fine |
---|---|---|
Navigant Cymetrix Corp.
Navigant Cymetrix Corp. Miscellaneous Commercial ServicesCommercial Services Navigant Cymetrix Corp. provides revenue cycle management solutions, consulting services and proprietary business intelligence to healthcare organizations. It provides comprehensive revenue cycle management solutions, consulting services and proprietary business intelligence, eligibility and financial counseling, comprehensive self-pay, clinical documentation integrity, coding, payment variance review, accounts receivable management and physician solutions to healthcare organizations and hospital-affiliated physician practices. The company was founded in 2001 by Michael Halberda and Jeffrey MacDonald and is headquartered in Irvine, CA. | Presidente | - |
9342-8530 QUÉBEC INC. | Corporate Officer/Principal | - |
Formazione di L. Blair Shamel
Rhodes College | Undergraduate Degree |
Emory University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
9342-8530 QUÉBEC INC. | Health Technology |
Aziende private | 4 |
---|---|
American Urological Association Education & Research, Inc.
American Urological Association Education & Research, Inc. Miscellaneous Commercial ServicesCommercial Services American Urological Association Education & Research, Inc. operates a urologic association. It offers urological clinical care through education, research and the formulation of health care policy. The company was founded on February 22, 1902 and is headquartered in Linthicum, MD. | Commercial Services |
California Prostate Cancer Coalition | |
Navigant Cymetrix Corp.
Navigant Cymetrix Corp. Miscellaneous Commercial ServicesCommercial Services Navigant Cymetrix Corp. provides revenue cycle management solutions, consulting services and proprietary business intelligence to healthcare organizations. It provides comprehensive revenue cycle management solutions, consulting services and proprietary business intelligence, eligibility and financial counseling, comprehensive self-pay, clinical documentation integrity, coding, payment variance review, accounts receivable management and physician solutions to healthcare organizations and hospital-affiliated physician practices. The company was founded in 2001 by Michael Halberda and Jeffrey MacDonald and is headquartered in Irvine, CA. | Commercial Services |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- L. Blair Shamel